How Breast Cancer Cells Share Drug Resistance
Author Information
Author(s): Jennifer Pasquier, Pierre Magal, Céline Boulangé-Lecomte, Glenn Webb, Frank Le Foll
Primary Institution: University of Le Havre
Hypothesis
Can P-glycoprotein transfer between breast cancer cells lead to acquired multidrug resistance?
Conclusion
The study confirmed that breast cancer cells can transfer P-glycoprotein to each other, which may contribute to drug resistance.
Supporting Evidence
- Cell-to-cell transfers of P-glycoprotein were observed in co-cultures of resistant and sensitive breast cancer cells.
- A mathematical model was developed to describe the dynamics of P-glycoprotein transfer.
- Flow cytometry was used to analyze P-glycoprotein expression and efflux activity over time.
Takeaway
Breast cancer cells can share a protein that helps them resist drugs, making it harder to treat the cancer.
Methodology
The study used co-cultures of drug-resistant and sensitive breast cancer cells and a mathematical model to analyze P-glycoprotein transfer.
Limitations
The study primarily focused on in vitro conditions, which may not fully represent in vivo environments.
Participant Demographics
The study involved human breast cancer cell lines, specifically MCF-7 and MCF-7/Doxo.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website